|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39 TWD | +1.17% |
|
-1.39% | -40.09% |
| May. 28 | Tanvex BioPharma, Inc.(TWSE:6541) dropped from S&P Global BMI Index | CI |
| Mar. 14 | Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Tanvex BioPharma, Inc. announced the appointment of Wen Chung Yeh as Chief financial officer with effect on November 13, 2023. Date of occurrence of the change: November 13, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -40.09% | 199M | |
| +9.83% | 115B | |
| +10.80% | 105B | |
| -10.84% | 22.71B | |
| -1.37% | 21.83B | |
| -10.67% | 18.18B | |
| -41.92% | 16.52B | |
| -15.11% | 16.01B | |
| +6.62% | 14.14B | |
| +17.53% | 10.71B |
TANVEX BIOPHARMA, INC. 
